Richard Newitter
Stock Analyst at Truist Financial
(4.08)
# 1,682
Out of 4,974 analysts
1028
Total ratings
47.3%
Success rate
5.3%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Reiterated: Buy | $22 → $23 | $19.23 | +19.60% | 15 | Sep 15, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | n/a | $43.87 | - | 54 | Sep 9, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Hold | n/a | $98.41 | - | 72 | Sep 9, 2026 | |
| MDT Medtronic | Reiterated: Hold | $86 → $99 | $93.75 | +5.60% | 49 | Sep 2, 2026 | |
| VCEL Vericel | Reiterated: Buy | n/a | $39.72 | - | 20 | Aug 20, 2026 | |
| IRTC iRhythm Holdings | Reiterated: Buy | n/a | $111.92 | - | 35 | Aug 19, 2026 | |
| TMCI Treace Medical Concepts | Reiterated: Hold | $4 → $5 | $4.58 | +9.17% | 37 | Aug 10, 2026 | |
| GMED Globus Medical | Reiterated: Buy | $100 | $74.69 | +33.89% | 56 | Aug 7, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Buy | $31 | $16.28 | +90.42% | 9 | Aug 7, 2026 | |
| CARL Carlsmed | Reiterated: Buy | $18 → $20 | $15.23 | +31.32% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $210 → $153 | $139.24 | +9.88% | 16 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 | $19.30 | +8.81% | 42 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $54 → $62 | $74.60 | -16.89% | 67 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $110 → $127 | $126.21 | +0.63% | 19 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $125 → $103 | $100.73 | +1.76% | 60 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $23 | $18.55 | +23.99% | 17 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $87 → $93 | $86.45 | +7.58% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $330 → $340 | $281.50 | +20.78% | 49 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 → $215 | $171.68 | +25.23% | 24 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $95 | $85.74 | +10.80% | 41 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $580 → $510 | $377.16 | +35.22% | 73 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $23.24 | -13.94% | 17 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $129.02 | - | 65 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $61.08 | - | 1 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $370 → $374 | $318.43 | +17.45% | 27 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $15.69 | -17.14% | 33 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $113.15 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.57 | n/a | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $240.83 | n/a | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $11.17 | n/a | 1 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $27.76 | n/a | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $148 | $164.67 | n/a | 1 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.46 | n/a | 10 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $5.62 | n/a | 3 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 57.96 → CHF 66.45 | CHF 55.18 | n/a | 11 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $150.27 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $44.96 | n/a | 13 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $260 → $250 | $185.92 | n/a | 16 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $7.60 | n/a | 3 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $770 | $147.00 | n/a | 26 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $141 | $46.95 | n/a | 14 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $45 | $102.03 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $56.22 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $47 | $23.71 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $140 | $267.20 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $4.5 | $8.88 | n/a | 1 | Jul 15, 2016 |
Beta Bionics
Sep 15, 2026
Reiterated: Buy
Price Target: $22 → $23
Current: $19.23
Upside: +19.60%
Boston Scientific
Sep 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $43.87
Upside: -
Zimmer Biomet Holdings
Sep 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $98.41
Upside: -
Medtronic
Sep 2, 2026
Reiterated: Hold
Price Target: $86 → $99
Current: $93.75
Upside: +5.60%
Vericel
Aug 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $39.72
Upside: -
iRhythm Holdings
Aug 19, 2026
Reiterated: Buy
Price Target: n/a
Current: $111.92
Upside: -
Treace Medical Concepts
Aug 10, 2026
Reiterated: Hold
Price Target: $4 → $5
Current: $4.58
Upside: +9.17%
Globus Medical
Aug 7, 2026
Reiterated: Buy
Price Target: $100
Current: $74.69
Upside: +33.89%
Tandem Diabetes Care
Aug 7, 2026
Reiterated: Buy
Price Target: $31
Current: $16.28
Upside: +90.42%
Carlsmed
Aug 6, 2026
Reiterated: Buy
Price Target: $18 → $20
Current: $15.23
Upside: +31.32%
Aug 6, 2026
Downgraded: Hold
Price Target: $210 → $153
Current: $139.24
Upside: +9.88%
Aug 5, 2026
Reiterated: Hold
Price Target: $21
Current: $19.30
Upside: +8.81%
Aug 4, 2026
Reiterated: Hold
Price Target: $54 → $62
Current: $74.60
Upside: -16.89%
Aug 4, 2026
Downgraded: Hold
Price Target: $110 → $127
Current: $126.21
Upside: +0.63%
Aug 4, 2026
Downgraded: Hold
Price Target: $125 → $103
Current: $100.73
Upside: +1.76%
Aug 4, 2026
Reiterated: Buy
Price Target: $21 → $23
Current: $18.55
Upside: +23.99%
Jul 31, 2026
Reiterated: Buy
Price Target: $87 → $93
Current: $86.45
Upside: +7.58%
Jul 31, 2026
Reiterated: Hold
Price Target: $330 → $340
Current: $281.50
Upside: +20.78%
Jul 30, 2026
Reiterated: Buy
Price Target: $180 → $215
Current: $171.68
Upside: +25.23%
Jul 24, 2026
Reiterated: Hold
Price Target: $95
Current: $85.74
Upside: +10.80%
Jul 17, 2026
Reiterated: Buy
Price Target: $580 → $510
Current: $377.16
Upside: +35.22%
Mar 2, 2026
Reiterated: Hold
Price Target: $20
Current: $23.24
Upside: -13.94%
Feb 27, 2026
Reiterated: Hold
Price Target: n/a
Current: $129.02
Upside: -
Jan 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $61.08
Upside: -
Jan 16, 2026
Downgraded: Hold
Price Target: $370 → $374
Current: $318.43
Upside: +17.45%
Dec 23, 2025
Reiterated: Hold
Price Target: $13
Current: $15.69
Upside: -17.14%
Jun 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $113.15
Upside: n/a
Jun 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $19.57
Upside: n/a
Oct 16, 2024
Rated: Buy
Price Target: n/a
Current: $240.83
Upside: n/a
Jun 20, 2024
Rated: Buy
Price Target: n/a
Current: $11.17
Upside: n/a
Apr 17, 2024
Reiterated: Buy
Price Target: n/a
Current: $27.76
Upside: n/a
Aug 22, 2023
Reiterated: Hold
Price Target: $148
Current: $164.67
Upside: n/a
Oct 7, 2021
Reiterated: Buy
Price Target: n/a
Current: $1.46
Upside: n/a
Sep 10, 2021
Initiated Coverage: Buy
Price Target: $20
Current: $5.62
Upside: n/a
Aug 17, 2021
Reiterated: Hold
Price Target: CHF 57.96 → CHF 66.45
Current: CHF 55.18
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: n/a
Current: $150.27
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $27
Current: $44.96
Upside: n/a
Aug 5, 2021
Rated: Hold
Price Target: $260 → $250
Current: $185.92
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $20
Current: $7.60
Upside: n/a
Jul 28, 2021
Rated: Buy
Price Target: $770
Current: $147.00
Upside: n/a
Jul 28, 2021
Rated: Hold
Price Target: $141
Current: $46.95
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $45
Current: $102.03
Upside: n/a
Jul 15, 2016
Reiterated: Buy
Price Target: $20
Current: $56.22
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $47
Current: $23.71
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $140
Current: $267.20
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $4.5
Current: $8.88
Upside: n/a